Cleared Traditional

K193319 - XyCAM RI, XyCAM RI System, XyCAM Retinal Imaging System

K193319 is an FDA 510(k) clearance for XyCAM RI, manufactured by Vasoptic Medical, Inc.. The device is a Class 2 Ophthalmic device with product code HKI cleared through the Traditional 510(k) pathway after a 182-day FDA review.

K193319 · Vasoptic Medical, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
182d
Days
Class 2
Risk

K193319 is an FDA 510(k) clearance for the XyCAM RI, XyCAM RI System, XyCAM Retinal Imaging System. Classified as Camera, Ophthalmic, Ac-powered (product code HKI), Class II - Special Controls.

Submitted by Vasoptic Medical, Inc. (Baltimore, US). The FDA issued a Cleared decision on June 1, 2020 after a review of 182 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1120 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Vasoptic Medical, Inc. devices

FDA 510(k) Submission Details - K193319

510(k) Number K193319 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 02, 2019
Decision Date June 01, 2020
Days to Decision 182 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 110d · This submission: 182d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HKI Device Classification - Class 2, Special Controls

Product Code HKI Camera, Ophthalmic, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HKI Camera, Ophthalmic, Ac-powered

All 104
Devices cleared under the same product code (HKI) and FDA review panel - the closest regulatory comparables to K193319.
VX650
K202221 · Luneau Technology Operations · Jan 2021
Optomed Smartscope M5 with Optomed Smartscope FA
K201325 · Optomed Oyj · Nov 2020
Canon non-mydriatic retinal camera CR series
K201122 · Canon, Inc. · Jul 2020
Mydriatic Hyperspectral Retinal Camera (MHRC-C1)
K200254 · Optina Diagnostics · Apr 2020
Fundus Camera
K190954 · Chongqing Bio Newvision Medical Equipment , Ltd. · Jan 2020
KOWA nonmyd 8
K191945 · Kowa Company , Ltd. · Sep 2019